We are live on ! Find out more
THRD

Third Harmonic Bio

Delisted

THRD was delisted on the 30th of July, 2025.

Fund managers haven’t disclosed any holdings of THRD yet.

THRD Hedge Fund Activity: Q1 2026 in Review

4 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q1 2026, worth a combined $110K — down 1.4% from $111K a quarter earlier.

Fund positioning in THRD was balanced in Q1 2026: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was RhumbLine Advisers, cutting an estimated $1.54K.

  • 4 institutional investors held Third Harmonic Bio (THRD) as of Q1 2026, unchanged from Q4 2025.
  • Funds reported $110K of Third Harmonic Bio stock for Q1 2026, down 1.4% quarter-over-quarter.
  • 0 funds opened new Third Harmonic Bio positions in Q1 2026 and 0 closed out.
  • The largest Third Harmonic Bio seller in Q1 2026 was RhumbLine Advisers, an estimated $1.54K sold.

Based on aggregated 13F filings for Q1 2026.